Discontinuation report ACT ETIDROCAL

Last updated on 2019-03-01 History
Report ID 76486
Drug Identification Number 02263866
Brand name ACT ETIDROCAL
Common or Proper name ETIDROCAL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ETIDRONATE DISODIUM CALCIUM
Strength(s) 400MG 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-02-28
Actual discontinuation date 2019-02-28
Remaining supply date 2018-05-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-03-01 English Compare
v2 2019-02-21 French Compare
v1 2019-02-21 English Compare